Mouse Major Histocompatibility Complex class II I-Ad (I-Ad) (I-Ad)

The MHC class II I-Ad peptide-binding groove is a specialized structural domain within the mouse Major Histocompatibility Complex (MHC) class II molecule, specifically the I-A isotype of the 'd' haplotype. It is formed by the folding of the alpha-1 and beta-1 domains of the H2-Aa and H2-Ab1 protein chains, creating a cleft that accommodates peptides typically 13 to 25 amino acids in length (UniProt: P01910, P04229). This groove plays a pivotal role in the immune system by capturing exogenous antigens and presenting them to CD4+ T-cell receptors, thereby initiating adaptive immune responses (Janeway's Immunobiology, 9th Edition). In research and drug development, the I-Ad groove is a significant target for investigating autoimmune diseases and vaccine efficacy, as it determines the repertoire of peptides that can trigger T-cell activation. Drugs like glatiramer acetate are known to interact with MHC class II grooves to modulate immune activity, often by competing with autoantigens for binding (PMID: 7507031). Understanding the specificity of the I-Ad groove is essential for designing peptide-based therapies and understanding the molecular basis of immune-mediated conditions in murine models.

Other names

H2-IAdH-2 class II antigen I-AdMHC II I-Ad peptide-binding cleftI-A^dH2-IA(d)

Competitive binding to the peptide-binding groove to prevent the presentation of autoantigens or to induce T-cell tolerance through altered peptide ligand signaling.